Neuropsychopharmacology

Question 1

what is the decision about whether to use pharmacologic medications based on?

Answer 1

1. To justify the use of medications, the child must first have a disorder or target symptoms with the potential for pharmacologic responsiveness.
2. the child’s level of impairment must cross a threshold of severity such that failure to treat with medication, given all the potential risks, would cause more harm.
   3, the child’s symptoms must be unresponsive or insufficiently responsive to nonpharmacologic interventions, or these interventions are not readily available in the community.
3. someone to monitor for SEs

Question 2

Ritalin

Answer 2

Methylphenidate

Methylphenidate (MPH) non-competitively blocks the reuptake of dopamine and noradrenaline into the terminal by blocking the dopamine transporter (DAT) and noradrenaline transporter (NAT), increasing levels of dopamine and noradrenaline in the synaptic cleft.

Question 3

Concerta

Answer 3

Methylphenidate, extended release

Question 4

Dexedrine

Answer 4

Dextroamphetamine, immediate release

Question 5

Vyvanse

Answer 5

Lisdexamfetamine

Question 6

Adderall

Answer 6

Amphetamine

Question 7

Strattera

Answer 7

Atomoxetine

Question 8

Catapres

Answer 8

Clonidine

Question 9

Guanfacine

Answer 9

Tenex
Intuniv

Question 10

what are the signs of peak concentrations of stimulants in ADHD?

Answer 10

Effects associated with peak concentrations include dysphoria, anxiety, agitation, or the “zombie” effect (i.e., overfocused and passive). Rebound effects include overactivity, talkativeness, excitability, irritability, and insomnia.